Product Description: Enfortumab is a monoclonal antibody targeting Nectin-4. Enfortumab can used for researching urothelial cancer[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Rosenberg JE, et al. Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy. J Clin Oncol. 2019;37(29):2592-2600.